Toll like receptors in allogeneic hematopoietic stem cell transplantation.

被引：0
|
作者：
Waghmare, AA
Hubbard, V
van den Brink, M
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2005年 / 53卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
293
引用
收藏
页码：S129 / S129
页数：1
相关论文
共 50 条
  • [31] Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation.
    Zhang, Shijia
    Shanley, Ryan
    Rashidi, Armin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [32] Donor lymphocyte infusions for the treatment of relapse after allogeneic hematopoietic stem cell transplantation.
    Riera, L
    Koziner, B
    MEDICINA-BUENOS AIRES, 2000, 60 (02) : 259 - 269
  • [33] Pre-emptive therapy of CMV infection in allogeneic hematopoietic stem cell transplantation.
    Dentamaro, T
    Cudillo, L
    Picardi, A
    Postorino, M
    Gallone, D
    Masi, M
    Amadori, S
    BONE MARROW TRANSPLANTATION, 1999, 23 : S63 - S63
  • [34] Prospective molecular identification of alloreactive CTL clones in allogeneic hematopoietic stem cell transplantation.
    O'Keefe, CL
    Sobecks, R
    Rodriguez, A
    Curtis, J
    Kuckowski, E
    Bolwell, BJ
    Maciejewski, JP
    BLOOD, 2004, 104 (11) : 324B - 324B
  • [35] An experimental and clinical study of CMV infection after allogeneic hematopoietic stem cell transplantation.
    Wu, DP
    Wu, XJ
    Li, CX
    Ma, X
    Sun, AN
    BLOOD, 2004, 104 (11) : 354B - 354B
  • [36] Proteomics in the clinical follow up of patients after allogeneic hematopoietic stem cell transplantation.
    Weissinger, EM
    Kaiser, T
    Kamaal, H
    Hertenstein, B
    Mischak, H
    Ganser, A
    BLOOD, 2003, 102 (11) : 244A - 244A
  • [37] Donor lymphocyte infusions in patients with leukemia after allogeneic hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Liu, YL
    Zhou, SY
    BLOOD, 2002, 100 (11) : 448B - 448B
  • [38] Amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation.
    Goh, YT
    Hwang, WYK
    Tan, P
    Ng, HJ
    Chuah, CTH
    Fook, SC
    Wong, C
    Tan, CH
    BLOOD, 2002, 100 (11) : 416A - 417A
  • [39] Prognostic Significance of Complement System Activation After Allogeneic Hematopoietic Stem Cell Transplantation.
    Rubio, Marie T.
    Durey-Dragon, Marie A.
    Wang, Yi
    Blouin, Jacques
    Jacquelin, Sebastien
    Milpied, Pierre
    Suarez, Felipe
    Delarue, Richard
    Buzyn, Agnes
    Varet, Bruno
    Fridman, Wolf H.
    Fremeaux-Bacchi, Veronique
    Hermine, Olivier
    BLOOD, 2009, 114 (22) : 479 - 479
  • [40] Treatment of autoimmune diabetic (NOD) mice with purified allogeneic hematopoietic stem cell transplantation.
    Chu, Y
    Edwards, C
    Jerabek, L
    Burge, M
    Weissman, IL
    Shizuru, JA
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 123 - 123
12345